Just ask Rebecca Cherubini. She has been struggling with multiple sclerosis for 15 years.

"I surrendered it to God," she said, "I'm like, 'If this is your will, I would love for You to change it. But if not, ok, then You need to give me the grace to deal.'"

Like most people with MS, Cherubini's came out of the blue when she was young.

"Blurred vision to the point where I started to become nervous about my driving," she recalled. "And then one day I was actually going to work and I pulled off."

In addition to vision problems, other symptoms include fatigue, trouble walking and difficulty thinking.

MS is an autoimmune disease. That's when the body's immune system mistakenly attacks healthy tissue. In the case of MS, the immune system attacks the outer portion of nerves in the brain and the spinal cord. It gets worse over time, and there is no cure.

"I want to be able to drive my kids to soccer," Cherubini said. "I don't want to be debilitated. I don't want to be in a wheelchair."

Now, Cherubini may get her wish. She's one of dozens of MS patients at the Ohio State Medical Center to test a new drug called Ocrelizumab.

The medicine works to stop the cells in the immune system from attacking the central nervous system. It's clearly effective. It's been shown to stop the disease in its tracks—not just the more common "relapsing" form of MS, but also the most aggressive type, called "primary progressive."

"Ocrelizumab was the first medication for primary progressive MS that actually worked," said Dr. Michael Racke, a neurologist at the Ohio State Wexner Medical Center who has been treating MS patients for 30 years.

He says patients call it a game-changer.

"They say, 'You know, I really haven't had any kinds of effects from my MS,' and that's really obviously quite satisfying as an MS physician who can remember the days when we really didn't have anything to treat patients," he said.

Cherubini told Dr. Racke she's delighted the drug has stopped the progression of her disease. (Screengrab: Ocrelizumab/via CBN News)

"I feel normal again. I was telling him, I just feel normal," she said.

Ocrelizumab is not like other MS drugs, such as the pills that have to be taken daily or the shots that come three times a week. It only involves an infusion, which typically lasts four hours, every six months.

"This medicine, I don't have to worry about it," Cherubini said. "I don't have to take it every day. I don't have to worry about ordering it. I don't have to worry about any reactions to it."

Ocrelizumab costs $65,000 a year, which believe it or not, is less than many of the leading MS drugs.

And while this breakthrough can stop the progression of MS, doctors still don't know what causes the disease, so prevention remains a mystery.

"If you look at identical twins, when one twin gets MS, 70 percent of the time the other identical twin, who clearly has the same genetics as their brother or sister, doesn't get MS," explained Dr. Racke.

Since MS is an inflammatory disease, things that cause inflammation, such as obesity, stress and smoking, could factor-in. Early studies show vitamin D might help prevent it.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Hundreds to 'March for Martyrs' in DC In 'Solidarity With Persecuted Christians'

Eleven Countries Express Their Opposition to UN Political Pandemic Declaration

Charge Dropped against Abortionist Accused of Running over Pro-Life Activist With His Car

Atheists Dismantle Longstanding Prayer Tradition, Reportedly Convince School Board to Remove 'Offensive' Invocations Before Meetings

US Navy Stops Drag-Queen Recruiting

School Board Votes to Continue Letting Transgender Students Use Whatever Restrooms They Want, Then Hundreds of HS Students Walk Out of Class in Protest

Huge Win: Judge Says Teachers Don't Have to Follow State's Gender Identity Secrecy Policy

Canada: Parents, Students, Citizens of All Faiths Unite in HUGE Nationwide Protest of LGBT Indoctrination in Schools

Maui's Hope Rising from the Ashes: Lahaina's Beloved Banyan Tree Sprouts New Life

Move of God at Texas A&M Shows 'No Signs of Slowing Down'; Hundreds Baptized in Corpus Christi

Israelis Object as UNESCO Declares Biblical Jericho a 'Palestinian Heritage Site'

Undesired Milestone: US National Debt Surpasses $33 Trillion

Irony Alert: Bay Area, Struggling to Recover from 'Defund The Police', Looks to Texas for Help

Mexico: Former Congressman Details 'Brainwashing,' Public Humiliation as Court Fines Him over Trans Comments: 'A Man Can Never Be a Woman'

They Were Too Young to Consent, but Now They're Old Enough to Sue

Canadians from Coast to Coast Join the Million March for Children on Wednesday, Protesting LGBT indoctrination in Schools #LeaveOurKidsAlone

Prophetic Encouragement during Rosh Hashanah from Charlie Shamp: '5784: The Year of the Open Door'

Constitution Day: We the People Have a More Perfect Union to Fight For

'Like Medieval Times': Finnish Politician Prosecuted For Biblical Views Reacts to 'Crazy' Trial, Issues Warning

'This Is What an Invasion Looks Like': Video Shows Mexican Train Reportedly 'Bursting' With Migrants Heading to US Southern Border